IN its fifth successive rise, the Medical Journal of Australia has reached its highest ever Journal Impact Factor (JIF) of 7.738, according to the 2020 Clarivate Analytics Journal Citation Report.
The MJA’s JIF has climbed from 3.369 in 2015, 3.675 in 2016, 4.227 in 2017, 5.332 in 2018, and 6.112 in the 2019 report, placing it firmly in the top 20 titles in Clarivate’s General and Internal Medicine category, ranked 17th in the world.
Laureate Professor Nicholas Talley, AC, editor-in-chief of the MJA, said that the result was further reward for the recommitment of the Journal to publishing high quality content.
“It is a tribute to the quality of Australian research and Australian researchers as well as the team at the Journal that the Clarivate JIF for the MJA has jumped to its highest ever level, from 6.112 last year to 7.738 this year,” said Professor Talley.
“Authors want to have an impact on medical practice and policy, and the MJA is an excellent choice for medical researchers and practitioners. Thank you for supporting the MJA.”
The Clarivate Journal Impact Factor is based upon numbers of citations of journal articles by other peer-reviewed journals.
In other MJA news, Professor Talley has agreed to extend his contract as Editor-in-Chief for a further two years.
Publication of your online response is subject to the Medical Journal of Australia's editorial discretion. You will be notified by email within five working days should your response be accepted.